| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 50.337 | 22.306 | 96.987 | 266.589 |
| Total Income - EUR | - | - | - | - | - | - | 50.337 | 22.306 | 96.987 | 266.589 |
| Total Expenses - EUR | - | - | - | - | - | - | 11.236 | 80.496 | 50.515 | 63.697 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 39.101 | -58.190 | 46.473 | 202.891 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 38.769 | -58.408 | 45.571 | 196.166 |
| Employees | - | - | - | - | - | - | 2 | 10 | 5 | 3 |
Check the financial reports for the company - Biosar Sole Msc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 12.168 |
| Current Assets | - | - | - | - | - | - | 50.992 | 59.658 | 162.506 | 284.540 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 50.923 | 54.914 | 158.715 | 279.900 |
| Cash | - | - | - | - | - | - | 69 | 4.744 | 3.791 | 4.639 |
| Shareholders Funds | - | - | - | - | - | - | 38.769 | -19.479 | 27.088 | 197.138 |
| Social Capital | - | - | - | - | - | - | 0 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 12.223 | 79.137 | 135.418 | 99.570 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Biosar Sole Msc S.r.l.